Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

被引:64
作者
Font, Patricia [1 ,2 ]
Loscertales, Javier [3 ]
Soto, Carlos [4 ]
Ricard, Pilar [5 ]
Munoz-Novas, Carolina [6 ]
Martin-Clavero, Estela [7 ]
Lopez-Rubio, Montserrat [8 ]
Garcia-Alonso, Luis [9 ]
Callejas, Marta [8 ]
Bermejo, Alfredo [10 ]
Benavente, Celina [11 ]
Ballesteros, Monica [1 ]
Cedena, Teresa [7 ]
Calbacho, Maria [12 ]
Urbina, Raquel [1 ]
Villarrubia, Jesus [12 ]
Gil, Santiago [13 ]
Maria Bellon, Jose [2 ]
Luis Diez-Martin, Jose [1 ,2 ]
Villegas, Ana [11 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Hematol, Madrid 28007, Spain
[2] Inst Invest Sanitaria Gregorio, Madrid, Spain
[3] Hosp Univ La Princesa, Dept Hematol, Madrid, Spain
[4] Fdn Jimenez Diaz, Dept Hematol, E-28040 Madrid, Spain
[5] Hosp Univ Fdn Alcorcon, Dept Hematol, Madrid, Spain
[6] Hosp Univ Infanta Leonor, Dept Hematol, Madrid, Spain
[7] Hosp Univ 12 Octubre, Dept Hematol, Madrid, Spain
[8] Hosp Univ Principe Asturias, Dept Hematol, Madrid, Spain
[9] Hosp Univ Getafe, Dept Hematol, Madrid, Spain
[10] Hosp Univ Fuenlabrada, Dept Hematol, Madrid, Spain
[11] Hosp Univ Clin San Carlos, Dept Hematol, Madrid, Spain
[12] Hosp Univ Ramon & Cajal, Dept Hematol, Madrid, Spain
[13] Hosp Univ Puerta de Hierro, Dept Hematol, Madrid, Spain
关键词
Myelodysplastic syndromes (MDS); RCUD; RARS; WHO classification; R-IPSS; PROGNOSTIC SCORING SYSTEM; REFRACTORY-ANEMIA; SYNDROMES MDS; CLASSIFICATION; PROPOSALS; VALIDATION; MUTATIONS; DIAGNOSIS; SURVIVAL; EXCESS;
D O I
10.1007/s00277-014-2252-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have shown the reproducibility of the 2008 World Health Organization (WHO) classification in myelodysplastic syndromes (MDS), especially when multilineage dysplasia or excess of blasts are present. However, there are few data regarding the reproducibility of MDS with unilineage dysplasia. The revised International Prognostic Scoring System R-IPSS described two new morphological categories, distinguishing bone marrow (BM) blast cell count between 0-2 % and > 2-aEuro parts per thousand < 5 %. This distinction is critical for establishing prognosis, but the reproducibility of this threshold is still not demonstrated. The objectives of our study were to explore the reliability of the 2008 WHO classification, regarding unilineage vs. multilineage dysplasia, by reviewing 110 cases previously diagnosed with MDS, and to study whether the threshold of a parts per thousand currency sign2 % BM blasts is reproducible among different observers. We used the same methodology as in our previous paper [Font et al. (2013) Ann Hematol 92:19-24], by encouraging investigators to include patients with < 5 % BM blasts. Samples were collected from 11 hospitals and were evaluated by 11 morphologists. Each observer evaluated 20 samples, and each sample was analyzed independently by two morphologists. Discordance was observed in 36/108 suitable cases (33 %, kappa test 0.503). Diagnosis of MDS with unilineage dysplasia (refractory cytopenia with unilineage dysplasia (RCUD), refractory anemia with ring sideroblasts (RARS) or unclassifiable MDS) was assessed in 33 patients, by either of the two observers. We combined this series with the cases with RCUD or RARS included in our 2013 paper, thus obtaining 50 cases with unilineage dysplasia by at least one of the observers. The whole series showed very low agreement regarding RCUD (5/23, 21 %) and RARS (5/28, 18 %). Regarding BM blast count, the threshold of a parts per thousand currency sign2 % was not reproducible (discordance rate 32/108 cases, kappa test 0.277). Our study shows that among MDS WHO 2008 categories, interobserver discordance seems to be high in cases with unilineage dysplasia. We also illustrate that the threshold of a parts per thousand currency sign2 % BM blasts as settled by the R-IPSS may be not easy to reproduce by morphologists in real practice.
引用
收藏
页码:565 / 573
页数:9
相关论文
共 28 条
  • [1] [Anonymous], 2001, Pathology and genetics of tumours of haematopoietic and lymphoid tissues
  • [2] Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course
    Bacher, Ulrike
    Kern, Wolfgang
    Alpermann, Tamara
    Schnittger, Susanne
    Haferlach, Claudia
    Haferlach, Torsten
    [J]. LEUKEMIA RESEARCH, 2012, 36 (07) : 826 - 831
  • [3] Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
    Bejar, Rafael
    Stevenson, Kristen E.
    Caughey, Bennett A.
    Abdel-Wahab, Omar
    Steensma, David P.
    Galili, Naomi
    Raza, Azra
    Kantarjian, Hagop
    Levine, Ross L.
    Neuberg, Donna
    Garcia-Manero, Guillermo
    Ebert, Benjamin L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) : 3376 - 3382
  • [4] BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
  • [5] Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
    Broseus, J.
    Alpermann, T.
    Wulfert, M.
    Brichs, L. Florensa
    Jeromin, S.
    Lippert, E.
    Rozman, M.
    Lifermann, F.
    Grossmann, V.
    Haferlach, T.
    Germing, U.
    Luno, E.
    Girodon, F.
    Schnittger, S.
    [J]. LEUKEMIA, 2013, 27 (09) : 1826 - 1831
  • [6] Brunning RD., 2008, WHO CLASSIFICATION T, P88
  • [7] Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification
    Font, P.
    Loscertales, J.
    Benavente, C.
    Bermejo, A.
    Callejas, M.
    Garcia-Alonso, L.
    Garcia-Marcilla, A.
    Gil, S.
    Lopez-Rubio, M.
    Martin, E.
    Munoz, C.
    Ricard, P.
    Soto, C.
    Balsalobre, P.
    Villegas, A.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (01) : 19 - 24
  • [8] Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management
    Garcia-Manero, Guillermo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (01) : 97 - 108
  • [9] Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients
    Germing, U
    Gattermann, N
    Strupp, C
    Aivado, M
    Aul, C
    [J]. LEUKEMIA RESEARCH, 2000, 24 (12) : 983 - 992
  • [10] Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction
    Germing, U
    Gattermann, N
    Aivado, M
    Hildebrandt, B
    Aul, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 724 - 728